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ABSTRACT 
We used double-label in situ hybridization to examine the cellular localization of 
5-ht5B receptor mRNA in relation to serotonin transporter mRNA in the rat dorsal 
raphe (DR) and central superior nucleus (CS, median raphe nucleus). 5-ht5B receptor 
mRNA hybridization signal was often found on serotonin transporter mRNA positive 
neuron profiles. The degree of cellular colocalization of these mRNAs notably varied 
among the different regions of the raphe nuclei. In the DR, cell bodies showing 5-ht5B 
receptor mRNA expression were abundant in the medial portions of the nucleus, all of 
them being also labeled for serotonin transporter mRNA. In contrast, in the 
ventrolateral regions (lateral wings) of the DR, we observed serotonin transporter 
mRNA-positive cells, but they were devoid of 5-ht5B receptor mRNA signal. In the CS, 
the level of coexpression of 5-ht5B receptor mRNA with serotonin transporter mRNA 
was high in the intermediate portions of the nucleus, however we were unable to 
detect specific 5-ht5B receptor mRNA hybridization signal in its caudal extent. Our 
results support the presence of 5-ht5B receptor in serotonergic neurons in the DR and 
CS, suggesting an autoreceptor role for this receptor subtype. 
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INTRODUCTION 
5-Hydroxytryptamine (serotonin; 5-HT) has a variety of functions in the brain 
(Leibowitz and Alexander, 1998; Barnes and Sharp, 1999) that are mediated by 
multiple receptor subtypes. These are currently classified into 7 families comprising 
14 different receptors (Hoyer et al., 1994). Some of these subtypes have been cloned 
by nucleotide sequence homology with other previously identified 5-HT receptors and 
their function is not well known yet. Such is the case of the two members of the 5-ht5 
receptor family, namely the 5-ht5A and 5-ht5B subtypes (Plassat et al., 1992; Wisden 
et al., 1993; Matthes et al., 1993; Erlander et al., 1993; Rees et al., 1994; Grailhe et 
al., 2001). The genes coding for these receptors have been found in rat, mouse and 
human brain, however the human 5-ht5B receptor gene does not encode a functional 
protein (Grailhe et al., 2001). The members of the 5-ht5 family are G-protein-coupled 
receptors, but their transduction mechanisms have not yet been identified. Thus, 
most authors found that recombinant 5-ht5A and 5-ht5B receptors stably expressed in 
different cell lines do not alter the levels of cAMP nor inositol phosphates in response 
to 5-HT (Plassat et al., 1992; Wisden et al., 1993; Matthes et al., 1993; Erlander et 
al., 1993; Francken et al., 1998), however, Francken et al. (1998) reported that 
human 5-ht5A receptors stably transfected in human embryonic kidney (HEK) 293 
cells functionally couple to pertussis toxin-sensitive G (Gi/Go) proteins and inhibit 
adenylate cyclase activity, whereas Grailhe et al. (2001) found that the human 5-ht5A 
receptor expressed in Xenopus oocytes is able to couple to the inwardly rectifying K+ 
channel GIRK1. The pharmacological profile of recombinant 5-ht5 receptors is 
different from other 5-HT receptor families, although it shares some similarities with 
5-HT1 receptors, such as high affinity for 5-carboxamidotryptamine (5-CT) and 
several ergot alkaloid derivatives including LSD (Plassat et al., 1992; Wisden et al., 
1993; Matthes et al., 1993; Erlander et al., 1993; Weiss et al., 1995; Bach et al., 
1996; Grailhe et al., 2001). The lack of selective ligands for 5-ht5 receptors has 
hindered a thorough pharmacological characterization, and the analysis of their 
localization and of their functional implications. Attempts to explore the 
autoradiographic distribution of 5-ht5 receptors in the mouse brain have shown 
putative 5-ht5 binding sites in the habenula, hippocampus, septum, olfactory bulb and 
raphe (Waeber et al., 1998; Grailhe et al., 1999). mRNA localization studies in the rat 
brain have demonstrated the presence of 5-ht5A and 5-ht5B receptor transcripts in 
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different areas, including piriform cortex, habenula and some hippocampal structures 
(Matthes et al., 1993; Erlander et al., 1993; Kinsey et al., 2001). Very high densities 
of 5-ht5B receptor mRNA have been described in the inferior olivary nucleus and 
raphe nuclei. The occurrence of 5-ht5B receptor mRNA in the dorsal raphe nucleus 
(DR) might be indicative of its presence in 5-HT neurons, since the DR is the brain 
area where most 5-HT-containing cell bodies of neurons that project to the forebrain 
are located (Dahlström and Fuxe, 1964; Steinbusch, 1981), implicating therefore an 
autoreceptor role of the 5-ht5B receptor.  
In order to investigate the presence of 5-ht5B receptor mRNA in serotonergic cells, 
we used double-label in situ hybridization histochemistry to simultaneously visualize 
5-ht5B mRNA and 5-HT transporter (5-HTT) mRNA as a marker for 5-HT neurons. We 
examined the expression of these mRNAs throughout the entire rostrocaudal extent 
of the anterior raphe nuclei projecting to the forebrain, that is, the DR and central 
superior nucleus (CS; also named median raphe nucleus). Together, these data 
might provide some clues on the functionality of 5-ht5B receptors in the rat brain. 
 
MATERIAL AND METHODS 
Specimens 
Adult male Wistar rats (n=18) (200-250 g b.w.) were purchased from Iffa Credo 
(Lyon, France). Animal care followed the Spanish legislation on “Protection of animals 
used in experimental and other scientific purposes” in agreement with European 
regulations (O.J. of EC L358/1 18/12/1986). Experimental procedures were approved 
by the required ethical committees and local authorities. The animals were kept in a 
controlled environment (12-hours light-dark circle and 22 ± 2ºC), with free access to 
food and water. The animals were sacrificed by decapitation, the brains rapidly 
removed, frozen on dry ice and stored at -20ºC. Tissue sections, 14 µm thick, were 
cut using a microtome-cryostat (HM500 M, Microm, Walldorf, Germany), 
thaw-mounted onto slides coated with APTS (3-aminopropyltriethoxysilane, Sigma, 
USA) and kept at –20ºC until use. 
 
Hybridization probes 
The oligodeoxyribonucleotide probes used were as follows: for the 5-HTT mRNA 
two probes were always used together, 5-HTT-probe 1, complementary to bases 
51-98, and 5-HTT-probe 2, complementary to bases 612-659 of the 5-HTT mRNA 
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sequence (Blakely et al., 1991) and were synthesized on a 380 Applied Biosystem 
DNA synthesizer (Foster City Biosystem, Foster City, USA) and purified on a 20% 
polyacrylamide / 8 M urea preparative sequencing gel. For 5-ht5B receptor mRNA one 
oligodeoxynucleotide complementary to bases 1065-1113, corresponding to the 
carboxy terminus of the 5-ht5B receptor sequence (Matthes et al., 1993) was custom 
synthesized and purified by HPLC by Amersham Pharmacia Biotech (Little Chalfont, 
United Kingdom). An additional oligonucleotide probe against the 5-ht5B receptor 
mRNA (nucleotides 315-362) was used in preliminary experiments. Evaluation of the 
oligonucleotide sequences with basic local alignment search tool (BLAST) of EMBL 
and GenBank databases indicated that the probes do not show any significant 
similarity with mRNAs other than their corresponding targets in the rat.  
Oligonucleotides were labeled either with 33P, 32P or with digoxigenin (Dig). For the 
radioactive method, oligonucleotides (2 pmol) were 3’-end-labeled with [33P] or 
[32P]-dATP (>3000 Ci/mmol; Amersham) using terminal deoxynucleotidyltransferase 
(Roche Diagnostics GmbH, Mannheim, Germany), purified by centrifugation using 
QIAquick Nucleotide Removal Kit (QIAGEN GmbH, Hilden, Germany). Alternatively, 
for the nonradioactive method, 100 pmol of oligonucleotide were labeled by 3’-end 
tailing with the same enzyme and Dig-11-dUTP (Roche Diagnostics GmbH) according 
to a previously described procedure (Schmitz et al., 1991). Dig-labeled 
oligonucleotides were purified by ethanol precipitation. 
 
In situ hybridization histochemistry procedure 
The protocols for single- and double-label in situ hybridization were based on 
previously described procedures (Tomiyama et al., 1997; Landry et al., 2000) and 
have been published elsewhere (Serrats et al., 2003). Frozen tissue sections were 
first brought to room temperature, fixed for 20 min at 4ºC in 4% paraformaldehyde in 
phosphate-buffered saline (1x PBS: 8 mM Na2HPO4, 1.4 mM KH2PO4, 136 mM NaCl, 
2.6 mM KCl), washed for 5 min in 3x PBS at room temperature, twice for 5 min each 
in 1x PBS, and incubated for 2 min at 21ºC in a fresh solution of predigested pronase 
(Calbiochem, San Diego, USA) at a final concentration of 24 U/ml in 50 mM Tris-HCl 
pH 7.5, 5 mM EDTA. The enzymatic activity was stopped by immersion for 30 sec in 
2 mg/ml glycine in 1x PBS. Tissues were finally rinsed in 1x PBS and dehydrated 
through a graded series of ethanol. 
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For hybridization, the radioactively labeled and/or the non-radioactively labeled 
probes were dissolved in a solution containing 50% formamide, 4x SSC (1x SSC: 150 
mM NaCl, 15 mM sodium citrate), 1x Denhardt’s solution (0.02% Ficoll, 0.02% 
polyvinylpyrrolidone, 0.02% bovine serum albumin), 10% dextran sulfate, 1% 
sarkosyl, 20 mM phosphate buffer pH 7.0, 250 µg/ml yeast tRNA and 500 µg/ml 
salmon sperm DNA. The final concentrations of radioactive and Dig-labeled probes in 
the hybridization buffer were in the same range (~ 1.5 nM). Tissue sections were 
covered with hybridization buffer containing the labeled probe/s, overlaid with 
Nescofilm coverslips (Bando Chemical, Kobe, Japan) and incubated overnight at 
42ºC in humid boxes. The sections were then washed four times (45 min each) in a 
buffer containing 0.6M NaCl and 10 mM Tris-HCl (pH 7.5) at 60ºC. 
 
Development of radioactive and non-radioactive hybridization signal 
Slides that had been hybridized only with 33P-labeled probes were directly 
dehydrated through graded series of ethanols and allowed to air-dry. In parallel, 
sections hybridized with Dig-labeled probe(s) were treated as described by Landry et 
al. (Landry et al., 2000). Thus, after washing, the slides were immersed for 30 min in 
a buffer containing 0.1 M Tris-HCl pH 7.5, 1 M NaCl, 2 mM MgCl2 and 0.5% bovine 
serum albumin (Sigma) and incubated overnight at 4ºC in the same solution with 
alkaline-phosphate-conjugated anti-digoxigenin-F(ab) fragments (1:5000; Roche 
Diagnostics GmbH). Afterwards, they were washed three times (10 min each) in the 
same buffer (without antibody), and twice in an alkaline buffer containing 0.1 M Tris-
HCl pH 9.5, 0.1 M NaCl, and 5 mM MgCl2. Alkaline phosphatase activity was 
developed by incubating the sections with 3.3 mg nitroblue tetrazolium and 1.65 mg 
bromochloroindolyl phosphate (Gibco BRL, Gaithersburg, USA) dissolved in 10 ml of 
alkaline buffer. The enzymatic reaction was stopped by extensive rinsing in alkaline 
buffer with the addition of 1 mM EDTA. The sections were then briefly dipped in 70% 
and 100% ethanol and air-dried.  
Sections incubated with radioactive probes (alone or in combination with Dig-
labeled oligonucleotides) were either exposed to Hyperfilm -max (Amersham) or 
dipped into Ilford K5 nuclear track emulsion (Ilford, Mobberly, UK) diluted 1:1 with 
distilled water. The sections were exposed in the dark at 4°C for 6 weeks, and finally 
developed in Kodak D19 (Kodak, Rochester, USA) for 5 min, and fixed in Ilford 
Hypam fixer (Ilford). 
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Specificity of the probes 
 
The specificity of the oligonucleotide probe used to detect 5-ht5B receptor mRNA 
was verified by Northern blot and RT-PCR analyses. Total RNA was extracted from 
different regions of the rat brain using Rneasy Maxi kit (QIAGEN). RNA samples (30 
µg) were electrophoresed on a 1% agarose gel, blotted onto a nylon membrane and 
UV cross-linked. The blot was stained with 0.04% (w/v) methylene blue in 0.5 M 
sodium acetate pH 5.2 for 10 min, and later bleached in water for 5 min. 
Pre-hybridization and hybridization were performed in a solution containing 5x SSPE 
(0.75 M NaCl, 0.05 M NaH2PO4, 0.004 M EDTA), 50% formamide, 5x Denhardt’s, 
0.2% SDS, 500 µg/ml ssDNA at 42ºC. The 32P-labeled 5-ht5B receptor probe was 
added at a concentration of 5 x 106 dpm/ml, hybridized overnight and washed in a 
buffer containing 2x SSC, 0.1% SDS at 42ºC. The blots were exposed to X-ray film 
(Biomax MR, Kodak) for 4 weeks.  
The RT-PCR procedure was performed as described before (Vilaró et al., 2002). 
The sequences of the PCR primers used were: sense primer 5’ 
GGCTGCAGCGTTGCCAGGTGAGC, bases 901-923 from XM_213869, and 
antisense primer 5’ CCACCATCATGGCGGCTCGCTTC, bases 1178-1200 from 
XM_213869. PCR reaction products (10 µl each) were run on a 3.5% MS-12 
(Pronadisa Hispanlab, Madrid, Spain) agarose gel and transferred to Hybond-N nylon 
membranes (Amersham). Membranes were incubated with the 33P-labeled 5-ht5B 
oligonucleotide probe, which was supposed to hybridize within the region amplified 
by the PCR primers. Several control experiments were carried out to determine the 
specificity of the signal obtained by in situ hybridization. 1) The thermostability of 
hybrids obtained was checked for every probe. 2) For a given oligonucleotide probe, 
the hybridization signal was completely blocked by competition of the labeled probe 
in the presence of 50-fold excess of the same unlabeled oligonucleotide. 3) For each 
mRNA species, at least two different oligonucleotide probes were assayed 
separately. Hybridization signal was considered specific only when the regional and 
cellular labeling obtained with both probes was independently identical. 4) To assure 
the specificity of the nonradioactive hybridization signal, we compared the results 
obtained with the same probe radioactively labeled. 
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Data analysis 
Hybridized tissue sections were examined with a Wild 420 macroscope (Leica, 
Heerbrugg, Germany), with a Nikon Eclipse E1000 microscope (Nikon, Tokyo, Japan) 
and with an Axioplan Zeiss microscope (Carl Zeiss, Oberkochen, Germany), 
equipped with bright- and dark-field condensers for transmitted light. A Darklite 
illuminator (Micro Video Instruments Inc, Avon, USA) was used to improve the 
visualization of autoradiographic silver grains and capture of dark-field images. 
Micrography was performed using a digital camera (DXM1200 3.0, Nikon) and 
analySIS Software (Soft Imaging System GmbH, Münster, Germany). Alternatively, 
microphotographs were taken with Kodak Ektachrome 64T (Kodak). The figures were 
prepared for publication using Adobe PhotoShop software (Adobe Software, san 
Jose, CA). 
5-HTT mRNA positive neurons were identified as cell profiles showing dark staining 
(alkaline phosphatase reaction product) surrounding or covering the nucleus. 5-ht5B 
receptor mRNA hybridization signal was considered positive when accumulations of 
silver grains over cell profiles were at least 3-fold higher than average background. 
Cell counting was performed manually at the microscope with the help of analySIS 
Software.  
The average densities of 5-ht5B receptor mRNA in different brain regions were 
evaluated semiquantitatively on film autoradiograms with the aid of an image analysis 
system (MCID M4, Imaging Research, St. Catherines, Ontario, Canada).  
 
RESULTS 
 
Controls of specificity  
The specificity of the probe used to detect 5-ht5B receptor mRNA in in situ 
hybridization studies was assessed by Northern blotting and RT-PCR. In the 
Northern blot (Fig. 1A), our oligonucleotide probe labeled two bands which would 
correspond to 5-ht5B mRNA species of 3000 and 1900 nucleotides reported by 
Erlander et al. (1993), however, we did not observe the third band of 1500 
nucleotides found by these authors. As expected, 5-ht5B mRNA was detected in 
samples from hippocampus and brainstem, but not in cerebellum. In the RT-PCR 
assay, our 5-ht5B receptor probe recognized a single band of the expected size (300 
bp) (Fig. 1B,C).  
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The probes directed against the mRNAs encoding the 5-ht5B receptor mRNA and 
5-HT transporter fulfilled the criteria of specificity previously described. Figure 2 
illustrates the hybridization signal obtained for 5-ht5B receptor mRNA at two different 
brain levels and the effect of incubation with an excess of the same, unlabeled probe, 
which completely blocks labeling.  
As an additional control of specificity of the hybridization probe, the presence of 
5-ht5B receptor mRNA was examined in brain areas other than the raphe nuclei. 
Labeled cells were found in few brain structures, including the pyramidal cell layer of 
the CA1 field of the hippocampus, medial habenula, intermediate layers of the 
entorhinal cortex, parasubiculum, and inferior olivary nucleus (not shown). The 
granule cells of the dentate gyrus and the lateral habenula presented a weak 
hybridization signal. A semiquantitative evaluation of the content of 5-ht5B receptor 
mRNA in several brain regions is reported in Table 1.  
  
Dorsal Raphe 
5-HTT mRNA hybridization signal was strong and allowed a clear visualization of 
individual cell profiles in the DR and its surroundings (Fig. 3). Between 70 and 300 
labeled cell bodies per section were counted in the DR, depending on the 
anteroposterior level. Different subpopulations of 5-HTT mRNA-positive cells could be 
identified within the DR, which exhibited differences in cell shape and density. Thus, 
most 5-HTT mRNA positive cells were located in the ventromedial and dorsomedial 
parts of the DR, just dorsal to the fasciculus longitudinalis medialis. In these two 
subnuclei, 5-HTT mRNA expressing cells were predominantly ovoid and densely 
packed, whereas in the lateral wings labeled cell profiles were either ovoid or spindle-
shaped and showed a more scattered distribution (Figs.3,4). 
Throughout the entire anteroposterior extent of the rat DR, 5-ht5B receptor mRNA 
signal was also strong, and it was found exclusively in the medial portion of the 
nucleus, corresponding to its ventromedial, dorsomedial, interfascicular and caudal 
parts (Figs. 3C, 4B). In contrast, no specific 5-ht5B receptor mRNA hybridization signal 
could be detected in the lateral wings of the nucleus (Figs. 3C, 4A).  
Dual labeling was performed to examine concomitant expression of 5-ht5B receptor 
and 5-HTT mRNAs on single tissue sections. Coexpressing cells were counted at a 
single-cell resolution at different anteroposterior levels of the DR and the results are 
depicted in schematic representations in Fig. 5. No double-labeled cells were found in 
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the lateral wings of the DR (Fig. 4A, 5). In contrast, a high degree of coexpression of 
both mRNAs was observed in the medial portion of the nucleus (Fig. 4B, 5). The level 
of colocalization in the medial part of the DR varied significantly (p<0.0001) 
throughout the rostrocaudal axis, ranging from 62%-85% of the population of 5-HTT 
mRNA positive cells of this subregion (see Fig. 6A). Within the boundaries of the DR, 
no 5-ht5B receptor mRNA hybridization signal could be observed in the absence of 
5-HTT mRNA labeling in our experimental conditions. 
 
Central Superior Nucleus 
5-HTT mRNA-positive cells in the CS displayed less dense packing than in DR, and 
were scattered around the midline, ventrally to the medial longitudinal fasciculus. 
5-ht5B receptor mRNA hybridization signal showed a pattern of expression similar to 
the 5-HTT mRNA in the CS.  
The same dual labeling approach mentioned above was used to localize cells 
which coexpressed 5-ht5B receptor mRNA and 5-HTT mRNA in the CS (Fig. 4C, D, 5). 
The proportions of 5-HTT mRNA-positive cells expressing 5-ht5B receptor mRNA 
varied depending on the level studied: at anterior portions of the CS, ~20% of 
serotonergic cells coexpressed 5-ht5B receptor mRNA, whereas at intermediate 
regions the degree of coexpression reached 75%. In contrast, no colocalization was 
observed in serotonergic cells of the posterior parts of the CS (see Figs. 4C,D, 5 and 
6B). Similar to the DR, 5-ht5B receptor mRNA labeling was always associated with 
5-HTT mRNA in the CS. 
DISCUSSION 
The main finding of this study is the detection of 5-ht5B receptor mRNA in some 
populations of 5-HTT mRNA-positive cells in the DR and CS. As 5-HTT mRNA is 
specifically expressed in serotonergic cells of the raphe nuclei, it can be considered a 
marker of 5-HT cell phenotype (Rattray et al., 1999). Therefore, our data indicate that 
5-ht5B receptor mRNA is present in some 5-HT neurons, suggesting an autoreceptor 
role for this receptor subtype. 
Although the presence of 5-ht5B receptor mRNA in the rat DR has been previously 
described (Matthes et al., 1993; Erlander et al., 1993), it remained to be established 
whether or not this receptor is expressed by the proper serotonergic neurons. Using a 
double in situ hybridization procedure we have now identified two types of 
serotonergic cells in the anterior raphe nuclei: double-labeled cells coexpressing 
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5-ht5B receptor and 5-HTT mRNAs, and 5-HTT mRNA-positive cells lacking 5-ht5B 
receptor mRNA. It is noteworthy that the localization of double-labeled cells was 
restricted to the medial portions of the DR (including the dorsomedial, ventromedial, 
interfascicular and caudal cell groups) and the intermediate CS. Double-labeled cells 
represented the large majority of 5-HT cells in these subregions, although the degree 
of coexpression varied depending on the rostrocaudal level of the nucleus. In 
contrast, 5-HTT mRNA-positive cells in the lateral wings of the DR were apparently 
devoid of 5-ht5B mRNA. These observations denote an intranuclear heterogeneity in 
the expression of 5-ht5B receptor mRNA in the anterior raphe nuclei. Such 
intranuclear differences in the expression of a putative autoreceptor raise the 
possibility for a differential functionality of serotonergic cells in these subregions of the 
anterior raphe nuclei.  
Abundant evidence is available in the literature indicating the existence of different 
neuronal subgroups in the DR, with distinct morphological and neurochemical 
features and particular neuroanatomic organization of their afferent and efferent 
connections (Steinbusch, 1981; Imai et al., 1986). For instance, cells located in the 
lateral wings of the DR are larger and less densely packed than cells in the other 
subnuclei (Steinbusch, 1981; Törk, 1990). Differential subregional distributions of 
neuronal afferents to the DR and CS have been reported by several groups (Peyron 
et al., 1998; Fite et al., 1999; Kirby et al., 2000; Goto et al., 2001). Also, a topographic 
organization of efferent pathways arising from the mesencephalic raphe nuclei is 
supported by numerous studies (Villar et al., 1988; Vertes, 1991; Gonzalo-Ruiz et al., 
1995; Simpson et al., 1998; Vertes et al., 1999; Janusonis et al., 1999; Kirifides et al., 
2001). Several groups agree in ascribing the origin of cortical 5-HT inputs to neurons 
located in medial portions of the DR. Thus, 5-HT pathways innervating the medial 
prefrontal, the piriform, and primary somatosensory (barrel field) appear to arise from 
the midline portion of the DR (Van Bockstaele et al., 1993), ventromedial DR (Datiche 
et al., 1995), and midline regions of the rostral DR (Kirifides et al., 2001), respectively. 
These latter observations are of particular interest in the context of the present work, 
since we found 5-ht5B receptor mRNA signal in most 5-HT cells in the medial aspect 
of the DR. Therefore, it could be speculated that 5-ht5B autoreceptors would operate 
in serotonergic projections to the cortex but not in projections to some subcortical 
structures, including some visual centers and trigeminal somatosensory nuclei, which 
receive serotonergic inputs from the lateral wings of the DR.  
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In addition to the raphe nuclei, 5-ht5B receptor mRNA is found in few other brain 
structures. As shown by in situ hybridization histochemistry (Matthes et al., 1993; 
Erlander et al., 1993; Kinsey et al., 2001), very high concentrations of 5-ht5B receptor 
mRNA are found in the medial nucleus of the habenula, inferior olivary nucleus and 
pyramidal cell layer of the CA1 field (but not CA3) of the hippocampus. The densities 
of 5-ht5B receptor mRNA are high in the DR and intermediate in the CS, as well as in 
the parasubiculum and the entorhinal cortex. Only low densities are present in the 
dentate gyrus and lateral nucleus of the habenula. The physiological functions of the 
5-ht5B receptor are still unknown, but some speculations can be put forward in basis 
to the neuroanatomical localization of its mRNA. For instance, the presence of 5-ht5B 
receptor mRNA in the inferior olive and hippocampus might suggest a role of this 
receptor in motor coordination and learning and memory (Scoville and Milner, 1957; 
Parent and Carpenter, 1996). Likewise, 5-ht5B receptors expressed in the habenula 
might be involved in the modulation of exploratory behavior (Lee and Huang, 1988). 
In fact, LSD, which has high affinity for recombinant 5-ht5B receptors (Wisden et al., 
1993), has been reported to alter locomotor and exploratory behavior (Mittman and 
Geyer, 1991).  Unfortunately, until specific antisera or selective ligands for the 5-ht5B 
receptor are available, it will be very difficult to properly study the physiological and 
functional role of this receptor in the mammalian brain.  
The presence of 5-ht5B receptor mRNA in some populations of serotonergic 
neurons in the DR and CS described here suggests an autoreceptor role for this 
neuroreceptor. The physiological function of 5-ht5B autoreceptors would most likely 
depend on their cellular location on cell bodies, dendrites and/or terminals of 5-HT 
neurons. To our knowledge, one single report has addressed the issue of the 
anatomical distribution of 5-ht5B receptor binding sites (Waeber et al., 1998). 
According to these authors, putative 5-ht5B receptors (both auto- and heteroreceptors) 
would be localized predominantly at the somatodendritic level. So far, the existence of 
three 5-HT autoreceptors (5-HT1A, 5-HT1B and 5-HT1D subtypes) is well established 
(Hoyer et al., 1994; Stamford et al., 2000). The 5-HT1A autoreceptor is expressed in 
the somatodendritic compartment of 5-HT neurons, where it controls cell firing as well 
as 5-HT synthesis and release, both locally and in projection areas, whereas 5-HT1B 
and 5-HT1D autoreceptors are located on 5-HT nerve terminals where they modulate 
5-HT release. In the case of 5-ht5B autoreceptors, it seems unlikely that they would 
control electrical activity of serotonergic neurons, because the decrease in firing of 
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these neurons elicited by treatment with selective 5-HT reuptake inhibitors (SSRIs) is 
fully reversed by selective 5-HT1A receptor antagonists (Gartside et al., 1995; 
Arborelius et al., 1995). In contrast, a possible role of 5-ht5B receptors on the 
regulation of 5-HT synthesis could be inferred from the observation that the reduction 
in 5-HT synthesis induced by SSRIs is not reversed neither by the 5-HT1A antagonist 
WAY 100,635 nor by the 5-HT1B/D antagonist GR 127,935, whereas these compounds 
do prevent the inhibition of 5-HT synthesis caused by 5-HT1A or 5-HT1B/D selective 
agonists, respectively (Moret and Briley, 1997; Barton and Hutson, 1999). In addition 
it is noteworthy that methiothepin, which shows a relatively high affinity for the 
recombinant 5-ht5B receptor (Matthes et al., 1993), increases the synthesis of 5-HT 
(Moret and Briley, 1997). It cannot be excluded that the 5-ht5A subtype might also 
participate in the mentioned effects on 5-HT synthesis, since 5-ht5A receptor–like 
immunoreactivity has been found in several raphe nuclei (Oliver et al., 2000). Further 
work is necessary to ascertain whether 5-ht5B receptors do act as autoreceptors and 
determine their functional relevance.  
In summary, our study shows the presence of 5-ht5B receptor mRNA in some 
5-HTT mRNA-positive cells of the rat DR and CS. This localization suggests that 
5-ht5B receptors might act as autoreceptors in specific populations of serotonergic 
neurons. In addition, the present report provides further evidence for the existence of 
clearly differentiated cell populations in the DR in terms of neurochemical 
characteristics. However, the actions of this putative autoreceptor and the relevance 
of the subregional variability in the expression of 5-ht5B receptor mRNA within the DR 
remain to be established. 
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Table 1. Estimated densities of 5-ht5B receptor mRNA in different regions of the 
rat brain.  
 
Brain region 5-ht5B receptor mRNA  
Cortex  
 Primary olfactory cortex - 
 Frontal cortex - 
 Parietal cortex - 
 Temporal cortex - 
 Retrosplenial cortex - 
 Entorhinal cortex, intermediate layers ++ 
 Entorhinal cortex, external layers + 
Basal ganglia and olfactory tubercle - 
Hippocampus  
 CA1 (pyramidal cell layer) ++++ 
 CA2 (pyramidal cell layer) - 
 CA3 (pyramidal cell layer) - 
 Dentate gyrus (granule cell layer) + 
 Subiculum - 
 Parasubiculum ++ 
Thalamus   
 Medial habenula ++++ 
 Lateral habenula + 
 Other thalamic nuclei - 
Hypothalamus - 
Amygdala - 
Midbrain and brainstem  
 Superior and inferior colliculi - 
 Parabigeminal nucleus - 
 Dorsal raphe nucleus +++ 
 Central superior nucleus ++ 
 Inferior olivary nucleus ++++ 
 
Data were obtained by microdensitometric analysis of film autoradiograms. Density of 
5-ht5B receptor mRNA hybridization signal: +: low; ++: intermediate; +++: high; ++++: 
very high;  – not  detected. 
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FIGURES 
 
 
 
Fig. 1. A: Northern blot analysis of the expression of 5-ht5B receptor mRNA. Total 
RNA samples from cerebellum, hippocampus and brainstem (30 µg each) were used. 
Two bands (arrowheads) of ~3,000 and ~1,900 nucleotides are detected in lanes 
from hippocampus and brainstem, while no signal can be observed in cerebellum. 
B,C: Expression of mRNA coding for 5-ht5B receptor detected by RT-PCR. Presence 
or absence of reverse transcriptase is indicated, respectively, by +rt and -rt. Sizes in 
basepairs of the relevant molecular weight markers are indicated. Ethidium bromide 
staining (B) of the RT-PCR products and (C) the hybridization signal obtained with 
the 33P-labeled 5-ht5B receptor oligonucleotide probe. 
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Fig. 2. Film autoradiograms showing the hybridization pattern obtained from brain 
sections taken at two different levels using the 32P-labeled 5-ht5B receptor probe 
alone (A, B) or in the presence of an excess of the unlabeled oligonucleotide (A’, B’). 
Note that the labeling in inferior olive (IO), dorsal raphe (DR), entorhinal cortex 
(EntCx) and parasubiculum (PaS) is strong in standard incubation conditions (A, B) 
and it is blocked in the corresponding control sections (A’, B’). Scale bar = 3 mm. 
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Fig. 3. Visualization of 5-HTT and 5-ht5B receptor mRNAs in the dorsal raphe. A: A 
consecutive section to B and C stained with cresyl violet for anatomical reference. 
The approximate limits of the DR and its subdivisions –lateral wings and medial 
portion- are depicted. B:  A bright-field photomicrograph where numerous cell profiles 
expressing 5-HTT mRNA are visualized using digoxigenin-labeled oligonucleotide 
probes. C:  A dark-field photomicrograph from an emulsion-dipped tissue section 
displaying 5-ht5B receptor mRNA signal in the DR. Note that 5-ht5B receptor mRNA 
signal is restricted to the medial portion of the DR (including dorsomedial, 
ventromedial and interfascicular parts), while the lateral wings show no specific 
hybridization signal. DR, dorsal raphe; mlf, medial longitudinal fasciculus; PAG, 
periaqueductal gray. Scale bar = 0.5 mm.  
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Fig. 4. High-magnification dark-field 
photomicrographs show the 
simultaneous detection of two species of 
mRNAs using a 33P-labeled 
oligonucleotide probe for 5-ht5B receptor 
mRNA (silver grains) and 
digoxigenin-labeled probes for 5-HTT 
mRNA (dark precipitate), in dorsal raphe 
lateral wings (A), medial portion of 
dorsal raphe (B), central superior 
nucleus (C and detail enlarged in D) and 
medial longitudinal fasciculus (mlf) (E).  
Black arrows point to double-labeled 
cells and white arrowheads point to 
single 5-HTT mRNA labeled cells. In the 
lateral wings of the dorsal raphe, 5-HTT 
mRNA is expressed in cells which do not 
display 5-ht5B receptor mRNA signal (A), 
whereas in the medial portion of the 
dorsal raphe (B), as well as in the 
central superior nucleus (C,D), most 
cells containing 5-HTT mRNA co-
express 5-ht5B receptor mRNA. Note that 
photomicrographs were taken in the 
plane of the autoradiographic grains and 
therefore cellular staining is slightly out 
of focus. E: the absence of labeling in 
white matter (mlf) in comparison with the 
labeled cells of the DR (arrow). Scale 
bar = 50 µm (A, for B,D; C for E).  
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Fig. 5. Schematic representations of the rat lower midbrain and upper pons showing 
the subregional location of cells coexpressing 5-ht5B receptor mRNA and 5-HTT 
mRNA (filled circles) and cells expressing only 5-HTT mRNA (empty circles) in the 
DR and CS. Each circle represents 3 labeled cell profiles. The drawings were 
modified from the atlas of Swanson (1998) representing levels from –7.10 mm to 8.3 
mm from bregma. AT: anterior tegmental nucleus; AQ: cerebral aqueduct; CS: 
central superior nucleus; DR: dorsal raphe; dscp: decussation of the superior 
cerebellar peduncle; IPN: interpeduncular nucleus; mlf: medial longitudinal 
fasciculus; tsp: tectospinal pathway; VTA: ventral tegmental area; VTN: ventral 
tegmental nucleus. 
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Fig. 6. Degree of co-localization of 5-ht5B receptor mRNA with 5-HTT mRNA in the 
medial portion of the DR (A) and in the CS (B). Bars indicate the total number of cell 
profiles co-expressing 5-HTT mRNA and 5-ht5B receptor mRNA (black bars) or single 
5-HTT mRNA-labeled cell profiles (white bars) per section in these nuclei. In the DR, 
only the medial portion was considered, including the ventromedial, dorsomedial and 
interfascicular portions of the nucleus, but not the lateral wings. Cells were counted in 
14 µm-thick coronal sections taken at eight different anteroposterior levels (1-8) 
comprised between planes –7.0 to –9.0 mm from bregma. Data are cell counts 
(mean ± SD) and were obtained from three animals.  
 
